Volume 19, Number 1—January 2013
Dispatch
Linezolid Dependence in Staphylococcus epidermidis Bloodstream Isolates
Spyros Pournaras
, Eleni Ntokou, Olympia Zarkotou, Kyriaki Ranellou, Katerina Themeli-Digalaki, Constantinos Stathopoulos, and Athanassios Tsakris
, Eleni Ntokou, Olympia Zarkotou, Kyriaki Ranellou, Katerina Themeli-Digalaki, Constantinos Stathopoulos, and Athanassios Tsakris
Table 1
Demographic and clinical characteristics of 27 patients with bloodstream infections who yielded linezolid-resistant Staphylococcus epidermidis, Greece, 2008–2010
| Patient characteristics | Finding |
|---|---|
| Mean age, y, ± SD | 46.9 ± 21.7 |
| Male sex, no. (%) | 16 (59.3) |
| Comorbidities >2, no. (%) | 8 (29.6) |
| Mean hospital stay, d ± SD | 27.1 ± 9.8 |
| Use of mechanical ventilation | |
|
Isolates recovered during ventilation, no. (%) |
21 (77.8) |
|
Mean duration, d ± SD |
23.4 ± 9.7 |
| Presence of central venous catheter | |
|
No. (%) patients |
27 (100) |
|
Mean duration, d ± SD |
27.1 ± 9.8 |
| Presence of foreign material, no. (%) | 11 (40.7) |
| Admission from other hospital, no. (%) | 6 (22.2) |
| Prior hospitalization, no. (%) | 10 (37.0) |
| Linezolid administration | |
|
No. (%) patients |
25 (92.6) |
|
Mean duration, d ± SD |
12.9 ± 7.4 |
| In-hospital deaths, % | 18.5 |
Page created: December 20, 2012
Page updated: December 20, 2012
Page reviewed: December 20, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.